Aiforia launches new AI platform
Translation: Original published in Finnish on 12/18/2025 at 8:20 am EET.
Aiforia announced on Wednesday the launch of a new generation AI platform that utilizes Vision Transformer technology. The new technology promises to accelerate the development of AI models and improve their performance, supporting the expansion of the company's product portfolio. The news has no direct impact on our forecasts, but we view the increased efficiency in product development positively, as it partly mitigates risks related to the company's innovation capabilities after cost cuts and supports its long-term competitiveness.
The new Foundation Engine solution enhances model development
Aiforia announced on Wednesday that it is expanding its AI platform with a new solution called Foundation Engine, which is based on the Vision Transformer architecture. According to the company, the new solution combines so-called foundation models, pre-trained on extensive image datasets, with task-specific annotations made by pathologists. Aiforia highlights that the key benefits of the technology are the acceleration of AI model development and the improved generalizability of models to different image datasets. The new technology will be deployed in Aiforia's own product development and will also be integrated into the Aiforia Create development tool available to customers.
The company referred to the benefits of the expansion in its own product development earlier in the fall, so the launch does not come as a particular surprise or put pressure on forecast changes. In any case, the acceleration of model development supports the company's goals to improve its operational efficiency. Aiforia has recently focused on optimizing its cost structure and securing its path to profitability. In our view, more efficient product development through new technology mitigates the risks of cost savings to the company's innovation pace and supports the company's ability to maintain competitiveness in the long term. In addition to supporting the expansion of the product portfolio in the clinical segment, which is central to Aiforia's growth strategy, the technology also fundamentally strengthens Aiforia's product for its research customers who develop their own models on the Aiforia platform.